USING ANTIBODIES FOR TREATING AUTOIMMUNE DISEASES IN PATIENT WITH INADEQUATE RESPONSE TO TNF-ALPHA INHIBITOR Russian patent published in 2013 - IPC A61K39/395 A61P37/02

Abstract RU 2489166 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: present invention refers to rituximab binding to B-cell surface markers, e.g. CD20. More specifically, the invention concerns using rituximab for treating rheumatoid arthritis in a mammal with an inadequate response to a TNF-alpha inhibitor.

EFFECT: invention provides reducing a joint damage in the patients.

6 cl, 1 tbl, 1 ex

Similar patents RU2489166C2

Title	Year	Author	Number
TREATMENT OF AUTOIMMUNE DISEASES IN PATIENT SUFFERING FROM INADEQUATE RESPONSE TO TNF-ALPHA INHIBITOR	2004	Mark Benyunes	RU2358762C9
AGENTS REDUCING B-CELL COUNT, INCLUDING CD20 ANTIBODIES OR FRAGMENTS THEREOF, FOR TREATING CHRONIC FATIGUE SYNDROME	2009	Mella Olav Fluge Ehjstejn	RU2519229C2
ANALYSIS OF NEUTRALISING ANTIBODIES AND ITS APPLICATION	2004	Beresini Maurin Song An	RU2370775C2
METHOD OF TREATING MULTIPLE SCLEROSIS	2005	Frona Pol A.	RU2384345C2
METHOD OF TREATING VASCULITIS	2005	Brunetta Pol Dzh.	RU2411956C2
METHOD OF TREATING JOINT INJURIES	2006	Totorajtis Mark Shou Timoti Mark Agarval Sunil Jokum Dehvid Kelman Ehriehlla	RU2457860C2
PURIFICATION OF ANTIBODIES WITH CATION-EXCHANGE CHROMATOGRAPHY	2008	Lebreton Benedikt Andre O'Konnor Debora Ehnn Safta Aurelija Sharma Mandakini	RU2498991C2
COMBINED THERAPY FOR TREATMENT OF AUTOIMMUNE DISEASES BY USING COMBINATION OF ELIMINATING B-CELLS AND IMMUNOREGULATORY ANTIBODIES	2001	Khanna Nabil	RU2285541C2
APPLICATION OF ANTI-CD40-ANTIBODIES	2006	Aukerman Sharon Lea Lukman Mokhammad	RU2442606C2
COMPOSITIONS OF ANTIBODIES	2014	Gokarn Yatin Zarraga Isidro E. Zarzar Dzhonatan Patapoff Tomas	RU2694055C2

RU 2 489 166 C2

Authors

Ben'Junes Mark

Dates

2013-08-10—Published

2008-10-14—Filed